Goldman Sachs Reinstates Sell on Kodiak Sciences, Announces $2 Price Target
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Andrea Tan has reinstated Kodiak Sciences (NASDAQ:KOD) with a Sell rating and set a price target of $2.

December 11, 2023 | 1:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs has reinstated a Sell rating on Kodiak Sciences with a $2 price target, which could negatively impact the stock's short term performance.
The reinstatement of a Sell rating by a prominent investment bank like Goldman Sachs, accompanied by a low price target, typically indicates a bearish outlook on the stock. This can lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100